Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Evofem Biosciences Inc (NQ: EVFM)
6.600 USD  +0.060 (+0.92%)
Official Closing Price  /  Updated: 4:50 PM EDT, Jun 19, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 48,503
Open 6.600
Bid (Size) 6.500 (23)
Ask (Size) 7.440 (1)
Prev. Close 6.540
Today's Range 6.550 - 6.720
52wk Range 1.790 - 7.240
Shares Outstanding 17,763,340
Dividend Yield N/A
Performance
YTD
+59.04%
+59.04%
1 Month
+23.83%
+23.83%
3 Month
+82.83%
+82.83%
6 Month
+93.55%
+93.55%
1 Year
+93.55%
+93.55%
Top News
More News
Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors
- Strategic financing to advance the commercialization of Evofem's lead asset, Amphora® - Read More
from PR Newswire
Evofem Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, announced today that its Chief Executive Officer, Saundra Pelletier, will present at the 2019 RBC Capital Markets... Read More
from PR Newswire
More News
Read More
Evofem Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update
from PR Newswire
Evofem Biosciences to Report First Quarter 2019 Results and Provide Corporate Update on May 7, 2019
from PR Newswire
Evofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b Sexually Transmitted Infections Trial of Amphora
from PR Newswire
STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Evofem Biosciences, Inc. – EVFM
from GlobeNewswire News Releases
PDL BioPharma Announces Equity Investment in Evofem Biosciences
from PR Newswire
Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma
from PR Newswire
Evofem Biosciences to Present at Needham Healthcare Conference
from PR Newswire
36 Stocks Moving In Monday's Mid-Day Session
category News , EVFM , BNED , and 46 more.
from Benzinga
31 Stocks Moving In Monday's Pre-Market Session
category TTM , TCX , MIK , and 39 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.